With the analysis among 1,799 patents, we discovered top 451 key players by total patent application. Otsuka Pharmaceutical Co., Ltd., Ciba-Geigy AG, Merck & Co., Inc. are dominant in this area. They take 10.34% of the total patent filing.
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 87
New Jersey, United States
Patent: 49
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 46
Nebraska, United States
Patent: 34
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 33
Heptares Therapeutics Ltd.
HERTFORD COUNTY, United Kingdom
Patent: 28
Sumitomo Chemical Co., Ltd.
Tokyo-to, Japan
Patent: 26
With the analysis among 15 patents, we discovered top 6 start-ups by total patent application. Pipeline Therapeutics, Inc., Shanghai Zhimeng Biopharma, Inc., Caldan Therapeutics Ltd. are active in this area.
Pipeline Therapeutics, Inc.
California, United States
Patent: 7
Shanghai Zhimeng Biopharma, Inc.
Shanghai Shi, China
Patent: 3
EDINBURGH, United Kingdom
Patent: 2
Fukuoka-ken, Japan
Patent: 1
HERTFORD COUNTY, United Kingdom
Patent: 1
Nanjing Fangshenghe Pharmaceutical Technology Co., Ltd.
With the analysis among related 195 patents applied in the last 5 years. We discover 75 most active companies in this area. The fast-growing Albireo AB, Otsuka Pharmaceutical Co., Ltd., Glaxosmithkline Intellectual Property Development Ltd. take 38.97% of patent filing during this period.
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 30
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 10
Heptares Therapeutics Ltd.
HERTFORD COUNTY, United Kingdom
Patent: 9
Bolt Biotherapeutics, Inc.
California, United States
Patent: 8
F. Hoffmann-La Roche Ltd.
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 5
Silverback Therapeutics, Inc.
Washington, United States
Patent: 4
Basel-Stadt, Switzerland
Patent: 3
Massachusetts, United States
Patent: 3
With the analysis among related 195 patents in last 5 years, we discover 42 new entrants. Albireo AB, Glaxosmithkline Intellectual Property Development Ltd., Bolt Biotherapeutics, Inc. are the most active new entrants in this area.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 10
Bolt Biotherapeutics, Inc.
California, United States
Patent: 8
Silverback Therapeutics, Inc.
Washington, United States
Patent: 4
Shanghai Zhimeng Biopharma, Inc.
Shanghai Shi, China
Patent: 3
Corcept Therapeutics, Inc.
California, United States
Patent: 2
Guangdong Sheng, China
Patent: 2
undefined undefined
Patent: 2
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
With the analysis among 219 patents, we discovered top 93 universities and scientific research institutions by total patent application. The Scripps Research Institute, University of British Columbia, The Johns Hopkins University are dominant in this area. They take 10.05% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 8
University of British Columbia
British Columbia, Canada
Patent: 6
The Johns Hopkins University
University of Southern California
California, United States
Patent: 4
Universidad Complutense de Madrid
President & Fellows of Harvard College
Massachusetts, United States
Patent: 4
Jiangsu Normal University
Jiangsu Sheng, China
Patent: 4
Shanxi Sheng, China
Patent: 4